Response to Patented Medicines Regulations Consultations
Canada’s significant investments in research and education have resulted in world-class scientific
discoveries. Governments at all levels are developing policies to nurture and further develop these assets in
order to grow Canada’s knowledge economy and ensure our future prosperity. In reviewing pricing policies,
PMPRB must look through this innovation lens to align with these values. Failing to do consider these larger and
long-term goals will be contrary – and ultimately detrimental – to Canadian innovation.